In an age when doctors are becoming increasingly frustrated with their patients, a common problem is patients taking the wrong medications, and they don’t have the right prescription.
Many of these patients are suffering from complications such as stroke, heart attack and kidney failure.
Doctors often don’t realise that these patients can be taking the right medications for various ailments, said G.S. Varma, president, Medical Consumers Federation of India (MCFI) India.
“Sometimes they are taking a medication which is not even approved for treating hypo.
They are taking it to treat another ailment.
The most common mistake made by doctors is prescribing incorrect medications, which could cause the patient to suffer from hypo, he added. “
This is an ongoing problem in the country,” said Varma.
The most common mistake made by doctors is prescribing incorrect medications, which could cause the patient to suffer from hypo, he added.
The MCFI, along with its sister body the Medical Consumers Alliance, has been lobbying the government to ban all unnecessary medications in India.
Some states are also banning the use of the drug, known as Methylprednisolone (MP), in the wake of a surge in the number of patients who developed hypo after a botched treatment.
MP is widely used in India as a treatment for stroke, kidney failure and heart failure, but there are few medicines available for hypo treatment, said Vibhu Sankaran, director general, Pharmaceutical & Healthcare Regulatory Authority of India.
A recent study showed that a whopping 80% of patients taking MP in India do not have a valid prescription.
“MP can be used for a variety of illnesses.
But it is extremely risky and should be restricted in India,” he added, adding that the use is growing.
Medical professionals in India have long been known to make mistakes, but this time it is doctors who are getting the blame, said Dr. Anupam Vittal, professor of obstetrics and gynecology at the University of Michigan.
“There is a huge amount of concern.
It is very serious, but doctors need to learn from it,” said Dr Vittal.
“What is happening in India is that doctors are getting a little bit more lenient,” said Gaurav, another member of the MCFI.
“I do believe that the drug should be banned in India, but not to the extent of banning all medicines,” he said.
The government has also announced it will ban the use and supply of MP in the next five years.
With the country’s healthcare system so fragmented, doctors are being asked to work on a patchwork of guidelines to keep patients safe and in a good health.
In the US, a US medical association has recommended doctors to stop prescribing the drug in the first three months of a patient’s life, but the Indian Medical Association (IMA) said the recommendation should be extended to 10 months.
“We are trying to find a balance between giving the patient the right medication and also giving them the right time to make that decision,” said Anupa Vittal of IMA India.
Despite the government’s efforts to ban the drug and its effects, the Indian medical community is still trying to get the message across that patients should be given the correct dosage and the right treatment for any condition.
A recent study in the journal Neurology revealed that patients in India were more likely to receive wrong doses of MP than in the US.
As doctors are often unable to diagnose hypo and are often reluctant to prescribe it, they can’t prescribe appropriate treatment to the patients.
“We do not know if there are other factors, such as age, mental condition, diabetes, lung disease and other factors that contribute to poor quality of care,” said Suresh Gopal, professor, medical department, Delhi University, who co-authored the study.